Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
IRIS
Show more
Class 1: Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases
Class 5: Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases
Class 42: Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology
Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 28 Mar 2023Application filedNew Application Entered
- 14 Sep 2023Assigned to an examining attorneyAssigned To Examiner
- 3 Oct 2023Office action issuedNon-Final Action Written
- 22 Dec 2023Response to office action filedTeas Response To Office Action Received
- 29 Jan 2024Final refusal issuedFinal Refusal Mailed
- 25 Oct 2024Approved for publicationApproved For Pub - Principal Register
- 28 Jan 2025Published for oppositionPublished For Opposition
- 18 Mar 2025Registered on the Principal RegisterRegistered-Principal Register
All 35 events
| 2025-03-18 | Registered-Principal Register |
| 2025-03-18 | Notice Of Registration Confirmation Emailed |
| 2025-01-28 | Published For Opposition |
| 2025-01-28 | Official Gazette Publication Confirmation E-Mailed |
| 2025-01-22 | Notification Of Notice Of Publication E-Mailed |
| 2024-10-25 | Teas/Email Correspondence Entered |
| 2024-10-25 | Approved For Pub - Principal Register |
| 2024-10-25 | Exparte Appeal Terminated |
| 2024-07-29 | Exparte Appeal Received At Ttab |
| 2024-07-29 | Jurisdiction Restored To Examining Attorney |
| 2024-07-29 | Ex Parte Appeal-Instituted |
| 2024-07-29 | Teas Request For Reconsideration Received |
| 2024-07-29 | Correspondence Received In Law Office |
| 2024-07-12 | Teas Voluntary Amendment Received |
| 2024-07-12 | Preliminary/Voluntary Amendment - Entered |
| 2024-04-23 | Application Extension To Response Period - Received |
| 2024-04-23 | Application Extension Granted/Receipt Provided |
| 2024-01-29 | Final Refusal Mailed |
| 2024-01-29 | Final Refusal E-Mailed |
| 2024-01-29 | Notification Of Final Refusal Emailed |
| 2023-12-23 | Teas/Email Correspondence Entered |
| 2023-12-22 | Teas Response To Office Action Received |
| 2023-12-22 | Correspondence Received In Law Office |
| 2023-10-03 | Non-Final Action Written |
| 2023-10-03 | Non-Final Action E-Mailed |
| 2023-10-03 | Notification Of Non-Final Action E-Mailed |
| 2023-09-29 | Notice Of Acceptance Of Amendment To Allege Use E-Mailed |
| 2023-09-28 | Use Amendment Accepted |
| 2023-09-23 | Use Amendment Filed |
| 2023-09-23 | Amendment To Use Processing Complete |
| 2023-09-22 | Teas Amendment Of Use Received |
| 2023-09-14 | Assigned To Examiner |
| 2023-04-18 | Notice Of Design Search Code E-Mailed |
| 2023-04-16 | New Application Office Supplied Data Entered |
| 2023-03-28 | New Application Entered |
Goods & services by class
Class 1 Chemicals
Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases
First use anywhere 9 Aug 2023 · First use in commerce 9 Aug 2023
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases
First use anywhere 9 Aug 2023 · First use in commerce 9 Aug 2023
Class 42 Technology & SaaS
Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology
First use anywhere 13 Jun 2023 · First use in commerce 13 Jun 2023
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 18 Mar 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.